Commitments and Contingencies (Details) - P3 Health Partners Inc. |
1 Months Ended | 3 Months Ended | 6 Months Ended | 11 Months Ended | 12 Months Ended | 22 Months Ended | 28 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Dec. 31, 2021
USD ($)
|
Dec. 31, 2021
USD ($)
|
Jun. 30, 2022
USD ($)
|
Dec. 31, 2021
USD ($)
plan
|
Jun. 30, 2021
USD ($)
|
Mar. 31, 2021 |
Jun. 30, 2022
USD ($)
|
Jun. 30, 2021
USD ($)
|
Dec. 02, 2021
USD ($)
|
Dec. 31, 2021
USD ($)
plan
|
Dec. 31, 2020
USD ($)
|
Dec. 31, 2019
USD ($)
|
Dec. 31, 2021
USD ($)
|
Jun. 30, 2022
USD ($)
|
|
| Loss Contingencies [Line Items] | ||||||||||||||
| Financial Designation, Predecessor and Successor [Fixed List] | Successor | Successor | Successor | Predecessor | Predecessor | Successor | Predecessor | Predecessor | Predecessor | Predecessor | ||||
| Number of health plans results in renegotiation | plan | 1 | 1 | ||||||||||||
| Additional payment to health plan | $ 10,600,000 | $ 10,600,000 | $ 10,600,000 | $ 10,600,000 | $ 10,600,000 | $ 10,600,000 | $ 10,600,000 | $ 10,600,000 | ||||||
| Operating Expenses. | 117,650,063 | $ 1,181,641,128 | $ 170,557,507 | $ 1,507,353,190 | $ 334,843,877 | $ 707,660,010 | $ 519,651,203 | $ 185,017,783 | ||||||
| Agreed claim settlement amount | $ 67,400,000 | $ 84,000,000.0 | ||||||||||||
| Percentage of total revenues recurring | 97.00% | 97.00% | ||||||||||||
| Renegotiation of Health Plan Agreement Due to Discrepancy [Member] | ||||||||||||||
| Loss Contingencies [Line Items] | ||||||||||||||
| Reduction in operating revenue | 3,600,000 | 3,600,000 | ||||||||||||
| Operating Expenses. | $ 7,000,000.0 | $ 7,000,000.0 | ||||||||||||
| X | ||||||||||
- Definition The amount of increase (decrease) in operating revenue. No definition available.
|
| X | ||||||||||
- Definition The number of health plans results in renegotiation of agreement. No definition available.
|
| X | ||||||||||
- Definition The percentage of total revenues recurring. No definition available.
|
| X | ||||||||||
- Definition Indicates designation of financial information when substantially all business or separately identifiable line of business transfers from one entity to another entity. Acceptable values are "Predecessor" and "Successor". Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount awarded to other party in judgment or settlement of litigation. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of loss contingency liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|